Believe Health review

Current public pages do not provide a price

Believe Health's public treatment pages do not publish a GLP-1 price, while the homepage promotes paying nothing if an applicant is not approved. That leaves the actual first and recurring charges to be established before a purchase decision. A prospective patient should not assume that a $0-if-not-approved promise identifies the cost after approval or creates a general refund guarantee. Ask for the prescription, supply, complete payment, and future billing terms in a form you can review before authorizing them.

An August 2026 gated offer listed compounded semaglutide at $149 per month and tirzepatide at $229, with dose-flat wording. Those amounts are historical context rather than newly confirmed public standing prices. A new customer needs the current selected offer, and an existing patient should use the terms applying to their actual account. The public absence of a price is not a reason to invent one, assume the service is free, or treat an older discount as guaranteed to remain available.

Two older categories did not identify a molecule

The earlier menu also listed GLP-1 Microdose at $199 and a daily GLP-1 Oral option at $229 without naming the medication in either category. The microdose amount was higher than the standard semaglutide figure, showing why a smaller-dose label should not automatically be read as a cheaper program. More importantly, the unknown molecule should stay unknown until the service explains it. A broad treatment category is not a sufficient description of what a clinician would prescribe or a pharmacy dispense.

If an oral or lower-dose preparation is proposed, ask for the active ingredients, formulation, quantity, rationale, and instructions. Do not infer semaglutide from a generic GLP-1 label or assume that a needle-free form is equivalent to an injection or an approved branded tablet. Compounded products are not FDA approved. Dose numbers and directions should not be transferred independently between routes or providers merely because the marketing uses a familiar medication category.

Approval should lead to identifiable clinical care

Believe describes physician-led telehealth and care across all 50 states without enumerating a complete service-area list. Confirm the actual clinician and prescription availability in your location before beginning an application. Ask which medical practice makes the decision, who remains responsible after the first order, and how to obtain their professional identity. A broad physician-led claim does not establish the clinician's specialty, guarantee a requested prescription, or explain the practical response to a question between supplies.

The public information does not name a dispensing pharmacy. Obtain that identity and the product's concentration, storage, usable period, and written labeling before paying. A general pharmacy assurance cannot answer who prepares an individual prescription or whom to contact about a shipment concern. The clinical and dispensing roles should remain distinct, with a usable contact for each. A platform support message is not automatically an assessment by the clinician responsible for treatment.

The final offer needs an exit explanation

Before agreeing, request the renewal amount, cancellation deadline, refund limits, and point at which an order becomes final. The historical dose-flat description does not establish every current term, and the approval-related $0 promise does not explain refunds after medication is prepared. If a longer plan is offered, ask how a clinical change affects remaining supplies and money already committed. The actual agreement should be clear before another recurring payment is authorized, rather than inferred from older menu labels.

Believe may interest someone comfortable evaluating a private quote after clinical screening, but its lack of public prices makes early comparison harder. The public material does not substantively address pregnancy, breastfeeding, postpartum, or PCOS care, so relevant needs deserve direct discussion and coordination. Choose on the current identified prescription, complete charge, pharmacy, accessible follow-up, and retained agreement. Keep August's prices and unnamed categories explicitly historical until the company supplies a clear current explanation.